Journal List > Ann Lab Med > v.41(2) > 1145788

Sung, Seo, Ko, Park, Hwang, Oh, Chun, Seong, Song, Song, and Park: Establishment of Pediatric Reference Intervals for Routine Laboratory Tests in Korean Population: A Retrospective Multicenter Analysis



Reference intervals defined for adults or children of other ethnicities cannot be applied in the evaluation of Korean pediatric patients. Pediatric reference intervals are difficult to establish because children are in their growing stage and their physiology changes continuously. We aimed to establish reference intervals for routine laboratory tests for Korean pediatric patients through retrospective multicenter data analysis.


Preoperative laboratory test results from 1,031 pediatric patients aged 0 month–18 years who underwent minor surgeries in four university hospitals were collected. Age- and sex-specific reference intervals for routine laboratory tests were defined based on the Clinical and Laboratory Standards Institute (CLSI) EP28-A3c guidelines.


The pediatric reference intervals determined in this study were different from existing adult reference intervals and pediatric reference intervals for other ethnicities. Most tests required age-specific partitioning, and some of those required sex-specific partitioning for at least one age-partitioned subgroup. Erythrocyte sedimentation rate, monocyte percentage, basophil percentage, activated partial thromboplastin time, glucose, cholesterol, albumin, bilirubin, chloride, and C-reactive protein did not show any difference between age- or sex-partitioned subgroups.


We determined Korean pediatric reference intervals for hematology, coagulation, and chemistry tests by indirect sampling based on medical record data from multiple institutions. These reference intervals would be valuable for clinical evaluations in the Korean pediatric population.


Reliable reference intervals for laboratory tests are critical guides for clinicians to diagnose diseases or make medical decisions [1]. The Clinical and Laboratory Standards Institute (CLSI) EP28-A3c guidelines describe procedures for establishing reference intervals in a clinical laboratory [2]. Although reference intervals established for a specific population using a specific platform can be transferred to other laboratories after appropriate verification, intervals for adults cannot be reliably adopted for the interpretation of test results of pediatric patients. Pediatric reference intervals should reflect not only age and sex, but also the ongoing growth and development of children [2-5]. Efforts have been made to establish reliable pediatric reference intervals, including studies from the Canadian Laboratory Initiative in Pediatric Reference Intervals (CALIPER) [6-8], German Health Interview and Examination Survey for Children and Adolescents [9, 10], and Children’s Health Improvement through Laboratory Diagnostics in the USA [11, 12]. However, some ethnic group studies revealed that ethnicity influences certain test values, such as alanine aminotransferase (ALT) and total protein concentrations [8], and ferritin, total thyroxine, cobalamin, and 25-OH vitamin D in East Asians [13]; thus, reference intervals established for Caucasian populations cannot simply be extrapolated to Asian populations. Another prospective analysis revealed a significant effect of ethnicity on biochemical markers, including 25-OH vitamin D, ferritin, follicle-stimulating hormone, and immunoglobulin M [14]. Therefore, ethnic-specific reference intervals should be determined for certain biochemical markers. There are many previous efforts and some published studies about Korean pediatric reference intervals for biochemical markers including hematology, chemistry, and hormone [15-18]. However, these studies have limitations to assess dynamic age-dependent change in pediatric population. For instance, neither neonates nor infants were included in the reference population [15, 16], test samples taken at specific time point from children who underwent 1-year-old check-up, not from whole pediatric period were analyzed [17], or age group between neonate and adult was classified as ‘children’ without additional subdivision [18]. Korean pediatric reference intervals that cover whole age range have not been established to date.
Establishing pediatric reference intervals is challenging. Especially, collecting a sufficient number of blood samples from healthy children for reference interval establishment and validation are problematic. A small sample size renders the application of simple, nonparametric statistical methods less reliable and requires the use of complicated analytical methods [3, 5, 19, 20]. The CLSI EP28-A3c guidelines suggest conducting a multicenter trial to overcome these problems [2]. Data from multiple centers can be pooled to establish reference intervals when the comparability of the test methods is ensured.
Currently, pediatric reference intervals are rarely provided when laboratory test results are reported in Korea, and when provided, they are usually based on studies in other ethnic populations. Moreover, existing reference intervals were established using old measurement methods, and instruments and are not applicable to current methods or instruments used in laboratories. Therefore, we aimed to establish reliable ageand sex-specific Korean pediatric reference intervals for hematology, coagulation, and chemistry tests.


Data collection

Four university hospitals, i.e., Seoul National University Hospital (SNUH, Seoul), Seoul National University Bundang Hospital (SNUBH, Seongnam), Asan Medical Center (AMC, Seoul), and Kangnam Sacred Heart Hospital (KSHH, Seoul), Korea, participated in this retrospective study. Patients aged 0 month–18 years who visited any of the hospitals between June 2010 and August 2015 were selected for potential inclusion in this study. No analytical drift was noted in any of the hospitals during the period of data collection, including alteration in instrument or reagent, and a notable internal quality control issue.
In accordance with CLSI EP28-A3c guidelines, to obtain data from “presumed healthy” individuals [2, 21], patients who underwent routine preoperative laboratory evaluation for minor surgery in the departments of general surgery, orthopedics, plastic surgery, thoracic surgery, ophthalmology, otorhinolaryngology, urology, dermatology, and dental surgery were considered as the “healthy” pediatric population. Preoperative laboratory test results of these patients were collected as reference values, following the indirect sampling method [2]. Basic demographic and laboratory data were extracted from the medical records to exclude patients with “unhealthy” general conditions or any underlying diseases. Patients with the following conditions were considered “unhealthy” and were therefore excluded: those taking prescribed medicines, those with any other comorbidity, those with febrile disease within two weeks before blood sampling for laboratory tests, those whose planned surgery was canceled after assessment of the laboratory test results, and those with other diseases requiring treatment at the time of blood sampling. As bone-specific alkaline phosphatase is elevated when bone injuries occur [22, 23], ALP values from orthopedic patients were considered inappropriate for the present study and were excluded.
The patients included in the final analysis largely had mild diseases unlikely to affect the laboratory test results. Only results from samples that passed the acceptance criteria of each hospital for each test, including volume, and were verified without warning or additional comment about hemolytic, icteric, or lipemic interferences, were included.
Referring to previous studies [8, 24] and considering the size of the reference group, the patients were divided into six subgroups by age: 0–3 months, 4–11 months, 1–6 years, 7–12 years, 13–15 years, and 16–18 years, and two subgroups by sex, to establish ageand sex-partitioned pediatric reference intervals. Finally, we extracted data for a total of 1,031 Korean pediatric patients from the four hospitals, including 401, 302, 228, and 100 patients from SNUH, AMC, SNUBH, and KSHH, respectively. The size of the aforementioned age-partitioned six subgroups was 44 (22 boys, 22 girls), 258 (140 boys, 118 girls), 415 (231 boys, 184 girls), 141 (76 boys, 65 girls), 101 (49 boys, 52 girls), and 72 (31 boys, 41 girls), respectively (Supplemental Data Table S1).
The study protocol was approved by the Institutional Review Board of each participating hospital. Informed consent was waived as this was a minimal risk study using only the test results stored in a database.

Laboratory tests and analytical methods

Preoperative routine laboratory test results were used for the reference interval analysis. The laboratory tests included hematology: white blood cell count with absolute neutrophil count, percentage of neutrophils, lymphocytes, monocytes, eosinophils, and basophils; red blood cell (RBC) count with mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC), hemoglobin (Hb), hematocrit (Hct), RBC distribution width (RDW) and erythrocyte sedimentation rate (ESR); platelet count with mean platelet volume (MPV), plateletcrit (PCT) and platelet distribution width (PDW); coagulation: prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen; chemistry: calcium (Ca), phosphorus (P), blood urea nitrogen (BUN), creatinine (Cr), protein, albumin, uric acid, aspartate aminotransferase (AST), ALT, ALP, bilirubin, glucose, cholesterol, sodium (Na), potassium (K), chloride (Cl), total CO2 (TCO2), and C-reactive protein (CRP).
For hematology tests, Sysmex XE-2100 (Sysmex Corporation, Kobe, Japan) was used in SNUH, SNUBH, and AMC, and Advia2120 (Siemens, Washington, DC, USA) in KSHH. For coagulation tests, ACL TOP (Instrumentation Laboratory, Bedford, MA, USA) was used in SNUH and KSHH, Sysmex CA-7000 (Sysmex Corporation, Kobe, Japan) in AMC, and STA-R MAX (Diagnostica Stago Inc., Asnières, France) in SNUBH. For chemistry tests, TBA-c16000 (Toshiba, Tokyo, Japan) was used in SNUH, AU 5800 (Beckman Coulter, Brea, CA, USA) in SNUBH, COBAS 8000 (Roche Diagnostic International Ltd., Rotkreuz ZG, Switzerland) in AMC, and Hitachi 7600 (Hitachi, Tokyo, Japan) in KSHH.

Comparison of test methods

We conducted a test method comparison and bias estimation to ensure comparability of the data from the different hospitals using diverse platforms and analytical methods, and to evaluate the possibility of establishing common reference intervals applicable to multiple analytical platforms. Fifty-one pooled serum samples were prepared in SNUH using residual serum stored at 4°C for three days, with 2-mL aliquots from each sample set distributed to the participating hospitals, and subsequently evaluated at the day of receipt for chemistry tests for Ca, P, BUN, Cr, protein, albumin, uric acid, AST, ALT, ALP, total bilirubin, glucose, cholesterol, Na, K, Cl, and TCO2. We compared only chemistry tests because of the difficulty in controlling the many factors that are to be considered when preparing pooled samples to compare hematology and coagulation test methods, such as blood type and isoagglutinin, unexpected antibody, and the condition of the plasma in which the cells were incubated. The hematology and coagulation tests from diverse platforms were indirectly compared by reviewing external quality assessment result, and analyzing the results using Mann-Whitney U test; however, this did not provide evidence enough to justify data combining. Equivalence of the chemistry test results was evaluated by Deming regression: when the 95% confidence interval (CI) of the slope contained 1 and that of the intercept contained 0, and reference material for each analyte was available in the Joint Committee for Traceability in Laboratory Medicine (JCTLM) database [25], the data from each hospital were regarded valid for reference interval determination and were merged for analysis. Chemistry tests results obtained from a single instrument, TBA-c16000, and from multiple equivalent platforms were analyzed to determine platform-specific and common reference intervals, respectively, whereas results obtained at SNUH using Sysmex XE-2100 and ACL TOP were used to determine platform-specific reference intervals for hematology and coagulation tests.

Data analysis and reference interval determination

The data were analyzed as recommended by the CLSI EP28-A3c guidelines [2]. The approach to establish reference intervals was similar to that used in the CALIPER study [8]. First, distribution tables and scatter plots were generated to globally assess the data. When the raw data were not normally distributed, they were subjected to logarithmic or Box-Cox transformation, and then, outliers for each test, confirmed by applying the Tukey test twice, were removed [26]. Partitioning of the reference interval according to age and sex was evaluated by Harris and Boyd’s test, using the mean, standard deviation (SD), and sample size of the subgroups [1]. If no significant difference was found between the partitioned reference intervals of adjacent age or sex subgroups, these subgroups were merged and the reference intervals for the merged group were re-assessed against those for the adjacent subgroup using the Harris and Boyd’s test, until no mergeable subgroups remained. When the sample size of the subgroup was ≥ 120, we defined the 2.5th and 97.5th percentiles as the lower and upper reference limits, respectively, according to the nonparametric method, and the 90% CI of the limit was determined. When the sample size was < 120, the robust method reported by Horn, et al. [27] was used to set the reference intervals and calculate the 90% CI, except for a few tests, in which this method is inadequate to calculate the reference lower limit. The parametric method, which defines the range of mean ± 2SD as reference interval, was applied for these tests after Shapiro-Wilk normality test. Statistical analyses were performed using Excel 2013 (Microsoft, Redmond, WA, USA), IBM SPSS Statistics 23 (IBM, Armonk, NY, USA), EP Evaluator 11 (Data Innovations, Burlington, VT, USA), and MedCalc version 14.8.1 (MedCalc Software, Ostend, Belgium).



Details of the reference intervals for hematology testing using the Sysmex XE-2100 are shown in Table 1. Most hematology tests showed significantly different results between two or more adjacent age-partitioned subgroups. Especially, values for children younger than 3 months or 1 year tended to differ from those of older children. Sex-partitioned reference intervals were established for some tests in at least one age-partitioned subgroup. A few tests, including ESR, monocyte percentage, basophil percentage, and PDW, did not show any significant difference between ageor sex-partitioned subgroups; thus, all results for these tests were combined to establish common pediatric reference intervals.


Reference intervals for coagulation tests established on the basis of test results obtained at SNUH using ACL TOP are shown Table 2. In the coagulation tests, we observed age-specific differences between children younger and older than one year for PT and younger and older than 13 years for fibrinogen concentration, whereas aPTT did not show age-specific differences. None of the coagulation tests showed sex-specific differences.


Reference intervals for chemistry tests established using TBA-c16000 as well as from the various platforms are shown in Table 3. This table also presents pediatric reference intervals established in previous studies, including a single-center study in a Korean population established using Hitachi 7600 [15] and the CALIPER study using Abbott Architect c8000 [8]. Test items for which the multicenter results were equivalent to those obtained using the TBA-c16000 instrument in the method comparison test were combined to establish multicenter reference intervals.
For some test items, the comparison based on Deming regression revealed adequate equivalence (Supplemental Data Table S2) to results obtained from at least one of the other platforms, AU 5800, Cobas 8000, Hitachi 7600, and reference material was available in the JCTLM database (Supplemental Data Table S3); therefore, data obtained for these items were mergeable with those obtained using the TBA-c16000 instrument. Results of Ca testing on Cobas 8000 and Hitachi 7600, glucose testing on Cobas 8000, cholesterol testing on Hitachi 7600, Na testing on all instruments, and K and Cl testing on Cobas 8000 and AU 5800 were used to establish reference intervals (Table 3). For most chemistry tests, age-partitioned reference intervals were established. Glucose, cholesterol, albumin, bilirubin, Cl, and CRP did not show any difference between age-partitioned subgroups. For P, uric acid, protein, ALP, AST, and Cr, sex-specific reference intervals were established for at least one age-partitioned subgroup.
Hematology, coagulation, and chemistry tests that showed age-dependent changes are presented as scatter plots in Figs. 1, 2, and 3, respectively. In hematology, segmented neutrophil percentage, hemoglobin, and hematocrit tended to increase with age (Fig. 1B, 1I, and 1J), whereas WBC count, lymphocyte percentage, and platelets tended to decrease with age (Fig. 1A, 1C, and 1L). For chemistry, pediatric reference intervals established previously based mainly on a Caucasian population [8] are indicated as horizontal dashed lines in Fig. 3. Minor differences in reference intervals between ethnicities are indicated in Table 3; however, these differences were too small to be visible in Fig. 3. In Fig. 3, all mergeable multicenter data are plotted. BUN, uric acid, and Cr tended to increase with age (Fig. 3C, 3I, and 3D), whereas P, and K tended to decrease with age (Fig. 3B and 3K). Reference intervals for tests that showed age-dependent changes largely differed from adult reference intervals. Tests that did not show age-dependent changes and for which no age-specific reference intervals were established are presented as scatter plots in Supplemental Data Figs. S1 and S2.


Although indirect sampling for establishing reference intervals is controversial [28, 29], and the CLSI working group does not endorse this method as a primary approach [2], some studies support well-designed indirect sampling methods [30-33]. While the possibility of including “unhealthy” patients in the reference group cannot be completely excluded owing to the intrinsic limitation of this approach, best efforts to derive reliable, sophisticated results from data have been made by careful medical record review and discussion by the international CALIPER research team, which leads studies on the establishment of authoritative pediatric reference intervals. While we did select “presumed healthy” patients on the basis of medical record review, various statistical techniques are available to extract “healthy” population data from a mixed dataset using visualization or formulation, under the assumption that the reference values from the healthy population have a near-Gaussian distribution [21].
Age-specific reference intervals were required for most tests, except glucose, cholesterol, albumin, bilirubin, Cl, and CRP, which did not require any partitioning. Age partitioning of children younger or older than 3 months for Na was confirmed only in the multicenter analysis, which included a larger sample size than the single-center analysis. Sex-specific reference intervals were established for P, uric acid, protein, ALP, AST, and Cr in some age-partitioned subgroups, and for K only in the multicenter analysis. Generally, reference intervals were more strongly affected by age than by sex, which is in line with findings in previous studies [7, 8, 24, 32]. However, the influence of sex on the reference intervals in the present study was not significant or substantially smaller than that in previous studies [7, 8]. For example, the reference intervals for calcium, BUN, cholesterol, albumin, bilirubin, and ALT were affected by sex in at least one age-partitioned subgroup in these previous studies, whereas we did not observe an effect of sex for these tests. This may be due to the relatively small sample sizes of the sex-partitioned subgroups, thus reducing statistical power, or due to age-partitioning based on chronological age regardless of individual growth and sexual development, such as the Tanner stage.
Age-dependent increasing tendencies were observed for segmented neutrophil count, hemoglobin, hematocrit, BUN, uric acid, and Cr, whereas decreasing tendencies were observed for WBC count, lymphocyte percentage, platelets, P, and K. Age-dependent increasing tendencies for Cr, uric acid, and decreasing tendencies for P have been observed in previous studies [8, 15, 28]. Figs. 1, 2, and 3 show age-dependent changes in pediatric laboratory test results, which can lead to misinterpretation of “abnormal” results from pediatric patients as “normal” in reference to adult intervals or vice versa. Thus, adult reference intervals are inappropriate for interpreting results of pediatric patients.
Despite the best efforts to minimize disparities among platforms and methods, previous studies have reported such disparities arising from differences in instruments and testing principles used [5, 8], suggesting the necessity of establishing platformor methodology-specific reference intervals. Our study was initially designed as a multicenter trial for the establishment of Korean pediatric reference intervals, which generally are applicable to all analytical platforms. However, based on a method comparison, only items that showed sufficient comparability of test methods were included in the multicenter reference interval analysis. This difference between instruments may have contributed to the loss of ethnical influence like lower ALT level in the Asian population that was revealed in a previous study but not observed in our study (Table 3). Therefore, the reference intervals determined in the present study are valid only for specific platforms (hematology testing using Sysmex XE-2100, coagulation testing using ACL TOP, and chemistry testing using TBA-c16000) and the availability can be limited now because one of the platforms, Sysmex XE-2100 has been discontinued. However, some chemistry test results were highly equivalent to those obtained from TBA-c16000 and thus can be transferred to other platforms after validation.
The transferability of CALIPER reference intervals established using one platform to other platforms even if r2 is smaller than 0.95 has been previously assessed using statistical methods such as Deming regression rather than simple linear regression when r2 is larger than 0.70 [34]. Further, research groups have attempted to transfer CALIPER reference intervals to their own platform in practical trials [35, 36]. We assessed method comparability of different platforms using the protocol suggested in the CLSI EP09-A3 guidelines [37], which revealed a high correlation among the platforms, as shown in Supplemental Data Table S3. Thus, although results of a limited number of test items could be combined to determine pediatric reference intervals, most pediatric reference intervals for chemistry tests established in the present study can be adopted by other laboratories and utilized for patient evaluation after adequate validation [2], without the need for establishing institution-specific reference intervals.
Our study had some limitations. As a retrospective study, data were not obtained in a well-controlled condition. For example, blood samples for preoperative tests had not been taken under strictly controlled conditions considering diet or a fasting period, which might have affected the results of certain tests. Therefore, the influence of these factors cannot be completely excluded, although one study interpreted this characteristic of indirect sampling to well reflect “routine” pre-analytical and analytical conditions [33]. Additionally, the small sizes of some subgroups might have led to analytical inaccuracies despite the application of robust statistical methods. Although the analytical approach we used was developed to allow for establishing reliable reference intervals for small reference groups, broadening of the CI for the upper and lower reference limits is inevitable. In practice, lower reference limits of some tests or the 90% CI of those determined using the robust method showed negative values because of a small subgroup size. Sample size affects not only statistical power but also subgroup partitioning per se. As shown in Table 3, in the CALIPER study, age-specific reference intervals were established for the early neonatal period (0–14 days). However, we could not establish reference intervals for this age group, as our study did not include reference individuals of this age.
Further, the method comparison test was performed only for clinical chemistry tests on the platforms used in the participating hospitals (TBA-c16000, AU 5800, COBAS 8000, and Hitachi 7600). Therefore, hematology and coagulation test results from other instruments were unavailable to establish multicenter reference intervals by merging with those obtained from Sysmex XE 2100 and ACL TOP, although some tests showed comparable results in the diagnostic hematology program of Korean Association of External Quality Assessment (Supplemental Data Table S4) and Mann-Whitney U test (Supplemental Data Table S5). In addition, chemistry test results from other platforms that were not standardized or harmonized cannot be combined for analysis, even if the comparison test showed acceptable equivalence.
Considering the limitations of the present study, future studies designed in a prospective manner with direct reference individual sampling based on healthy community children with a larger sample size, strict control of the sample collection condition, and matching platforms between hospitals are required to establish reliable pediatric reference intervals.

Supplementary materials


We thank the CALIPER team for advice on statistical analysis.



JY Sung and JD Seo drafted the manuscript. JY Sung, DH Ko, MJ Park, and SM Hwang acquired data from each institution. JY Sung, JD Seo, and S Oh analyzed the data and interpreted the results. JY Sung, MJ Park, S Chun, MW Seong, J Song, SH Song, and SS Park designed the study. JD Seo and SH Song revised and approved the final manuscript. All authors reviewed the manuscript and provided critical feedback.


None declared.


This study was supported by the Quality Improvement Research Fund of the Laboratory Medicine Foundation (LMF) in 2014.


1. Horn PS, Pesce AJ. 2003; Reference intervals: an update. Clin Chim Acta. 334:5–23. DOI: 10.1016/S0009-8981(03)00133-5. PMID: 12867273.
2. CLSI. 2010. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. CLSI EP28-A3c. Third ed. Clinical Laboratory Standards Institute;Wayne, PA:
3. Jung B, Adeli K. 2009; Clinical laboratory reference intervals in pediatrics: the CALIPER initiative. Clin Biochem. 42:1589–95. DOI: 10.1016/j.clinbiochem.2009.06.025. PMID: 19591815.
crossref pmid
4. Schnabl K, Chan MK, Adeli K. 2008; 3. Pediatric reference intervals: critical gap analysis and establishment of a national initiative. EJIFCC. 19:115–22. PMID: 27683306. PMCID: PMC4975206.
pmid pmc
5. Schnabl K, Chan MK, Gong Y, Adeli K. 2008; Closing the gaps in paediatric reference intervals: the CALIPER initiative. Clin Biochem Rev. 29:89–96. PMID: 19107221. PMCID: PMC2605413.
pmid pmc
6. Adeli K. 2011; Closing the gaps in pediatric reference intervals: the CALIPER initiative. Clin Biochem. 44:480–2. DOI: 10.1016/j.clinbiochem.2011.02.017. PMID: 22036336.
crossref pmid
7. Chan MK, Seiden-Long I, Aytekin M, Quinn F, Ravalico T, Ambruster D, et al. 2009; Canadian Laboratory Initiative on Pediatric Reference Interval Database (CALIPER): pediatric reference intervals for an integrated clinical chemistry and immunoassay analyzer, Abbott ARCHITECT ci8200. Clin Biochem. 42:885–91. DOI: 10.1016/j.clinbiochem.2009.01.014. PMID: 19318027.
crossref pmid
8. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. 2012; Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 58:854–68. DOI: 10.1373/clinchem.2011.177741. PMID: 22371482.
crossref pmid
9. Kohse KP, Thamm M. 2011; KiGGS the German survey on children's health as data base for reference intervals. Clin Biochem. 44:479. DOI: 10.1016/j.clinbiochem.2011.02.016. PMID: 22036335.
10. Kurth BM, Kamtsiuris P, Hölling H, Schlaud M, Dölle R, Ellert U, et al. 2008; The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS-Study. BMC Public Health. 8:196. DOI: 10.1186/1471-2458-8-196. PMID: 18533019.
crossref pmid pmc
11. Flanders MM, Crist RA, Roberts WL, Rodgers GM. 2005; Pediatric reference intervals for seven common coagulation assays. Clin Chem. 51:1738–42. DOI: 10.1373/clinchem.2005.050211. PMID: 16120957.
crossref pmid
12. Clifford SM, Bunker AM, Jacobsen JR, Roberts WL. 2011; Age and gender specific pediatric reference intervals for aldolase, amylase, ceruloplasmin, creatine kinase, pancreatic amylase, prealbumin, and uric acid. Clin Chim Acta. 412:788–90. DOI: 10.1016/j.cca.2011.01.011. PMID: 21238443.
13. Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, Armbruster D, et al. 2013; Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem. 59:1393–405. DOI: 10.1373/clinchem.2013.204222. PMID: 23637247.
crossref pmid
14. Tahmasebi H, Asgari S, Hall A, Higgins V, Chowdhury A, Thompson R, et al. 2019; Influence of ethnicity on biochemical markers of health and disease in the CALIPER cohort of healthy children and adolescents. Clin Chem Lab Med. 58:605–17. DOI: 10.1515/cclm-2019-0876. PMID: 31874092.
15. Cho SM, Lee SG, Kim HS, Kim JH. 2014; Establishing pediatric reference intervals for 13 biochemical analytes derived from normal subjects in a pediatric endocrinology clinic in Korea. Clin Biochem. 47:268–71. DOI: 10.1016/j.clinbiochem.2014.09.010. PMID: 25241678.
crossref pmid
16. Nah EH, Kim S, Cho S, Cho HI, Nah EH. 2018; Complete Blood Count Reference Intervals and Patterns of Changes Across Pediatric, Adult, and Geriatric Ages in Korea. Ann Lab Med. 38:503–511. DOI: 10.3343/alm.2018.38.6.503. PMID: 30027692. PMCID: PMC6056383.
crossref pmid pmc
17. Lee HR, Shin S, Yoon JH, Roh EY, Chang JY. 2016; Reference Intervals of Hematology and Clinical Chemistry Analytes for 1-Year-Old Korean Children. Ann Lab Med. 36:481–8. DOI: 10.3343/alm.2016.36.5.481. PMID: 27374715. PMCID: PMC4940493.
crossref pmid pmc
18. Kim B, Lee MN, Park HD, Kim JW, Chang YS, Park WS, Lee SY. 2015; Dried blood spot testing for seven steroids using liquid chromatography-tandem mass spectrometry with reference interval determination in the Korean population. Ann Lab Med. 35:578–85. DOI: 10.3343/alm.2015.35.6.578. PMID: 26354345. PMCID: PMC4579101.
crossref pmid pmc
19. Ceriotti F. 2012; Establishing pediatric reference intervals: a challenging task. Clin Chem. 58:808–10. DOI: 10.1373/clinchem.2012.183483. PMID: 22377530.
crossref pmid
20. Shaw JL, Binesh Marvasti T, Colantonio D, Adeli K. 2013; Pediatric reference intervals: challenges and recent initiatives. Crit Rev Clin Lab Sci. 50:37–50. DOI: 10.3109/10408363.2013.786673. PMID: 23656169.
crossref pmid
21. Farrell CL, Nguyen L. 2019; Indirect reference intervals: harnessing the power of stored laboratory data. Clin Biochem Rev. 40:99–111. DOI: 10.33176/AACB-19-00022. PMID: 31205377. PMCID: PMC6544248.
pmid pmc
22. Beck GR, Sullivan EC, Moran E, Zerler B. 1998; Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3‐E1 osteoblasts. J Cell Biochem. 68:269–80. DOI: 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A.
crossref pmid
23. Stein GS, Lian JB, Owen TA. 1990; Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4:3111–23. DOI: 10.1096/fasebj.4.13.2210157. PMID: 2210157.
crossref pmid
24. Clifford SM, Bunker AM, Jacobsen JR, Roberts WL. 2011; Age and gender specific pediatric reference intervals for aldolase, amylase, ceruloplasmin, creatine kinase, pancreatic amylase, prealbumin, and uric acid. Clin Chim Acta. 412:788–90. DOI: 10.1016/j.cca.2011.01.011. PMID: 21238443.
25. Bureau International des Poids et Mesures. JCTLM database: laboratory medicine and in vitro diagnostics. Updated on Jan 2020.
26. Solberg HE, Lahti A. 2005; Detection of outliers in reference distributions: performance of Horn's algorithm. Clin Chem. 51:2326–32. DOI: 10.1373/clinchem.2005.058339. PMID: 16223885.
crossref pmid
27. Horn PS, Pesce AJ, Copeland BE. 1998; A robust approach to reference interval estimation and evaluation. Clin Chem. 44:622–31. DOI: 10.1093/clinchem/44.3.622. PMID: 9510871.
crossref pmid
28. Shaw JL, Cohen A, Konforte D, Binesh-Marvasti T, Colantonio DA, Adeli K. 2014; Validity of establishing pediatric reference intervals based on hospital patient data: a comparison of the modified Hoffmann approach to CALIPER reference intervals obtained in healthy children. Clin Biochem. 47:166–72. DOI: 10.1016/j.clinbiochem.2013.11.008. PMID: 24316101.
crossref pmid
29. Solberg HE. 1994; Using a hospitalized population to establish reference intervals: pros and cons. Clin Chem. 40:2205–6. DOI: 10.1093/clinchem/40.12.2205. PMID: 7988005.
crossref pmid
30. Arzideh F, Brandhorst G, Gurr E, Hinsch W, Hoff T, Roggenbuck L, et al. 2009; An improved indirect approach for determining reference limits from intra-laboratory data bases exemplified by concentrations of electrolytes. J Lab Med. 33:52–66. DOI: 10.1515/JLM.2009.015.
31. Hoffmann RG. 1963; Statistics in the practice of medicine. JAMA. 185:864–73. DOI: 10.1001/jama.1963.03060110068020. PMID: 14043090.
crossref pmid
32. Zierk J, Arzideh F, Rechenauer T, Haeckel R, Rascher W, Metzler M, et al. 2015; Ageand sex-specific dynamics in 22 hematologic and biochemical analytes from birth to adolescence. Clin Chem. 61:964–73. DOI: 10.1373/clinchem.2015.239731. PMID: 25967371.
33. Jones GRD, Haeckel R, Loh TP, Sikaris K, Streichert T, Katayev A, et al. 2018; Indirect methods for reference interval determination-review and recommendations. Clin Chem Lab Med. 57:20–9. DOI: 10.1515/cclm-2018-0073. PMID: 29672266.
34. Estey MP, Cohen AH, Colantonio DA, Chan MK, Marvasti TB, Randell E, et al. 2013; CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort. Clin Biochem. 46:1197–219. DOI: 10.1016/j.clinbiochem.2013.04.001. PMID: 23578738.
crossref pmid
35. Araújo PA, Thomas D, Sadeghieh T, Bevilacqua V, Chan MK, Chen Y, et al. 2015; CLSI-based transference of the CALIPER database of pediatric reference intervals to Beckman Coulter DxC biochemical assays. Clin Biochem. 48:870–80. DOI: 10.1016/j.clinbiochem.2015.06.002. PMID: 26070714.
crossref pmid
36. Abou El Hassan M, Stoianov A, Araújo PA, Sadeghieh T, Chan MK, Chen Y, et al. 2015; CLSI-based transference of CALIPER pediatric reference intervals to Beckman Coulter AU biochemical assays. Clin Biochem. 48:1151–9. DOI: 10.1016/j.clinbiochem.2015.05.002. PMID: 25979809.
crossref pmid
37. CLSI. 2013. Measurement procedure comparison and bias estimation using patient samples; approved guideline. CLSI EP09-A3. Third ed. Clinical Laboratory Standards Institute;Wayne, PA:


Fig. 1
Scatter plots of hematology test results showing age-dependent changes. Results obtained at SNUH using the Sysmex XE-2100 platform after outlier exclusion are presented. (A–D) WBC count, percentage of segmented neutrophils, lymphocytes, and eosinophils. (E–K) RBC count, MCV, MCH, MCHC, hemoglobin concentration, hematocrit, and RDW. (L–N) platelet count, PCT, and MPV. Blue and red dots represent male and female children enrolled in the present study. The gray line represents the trend line; its equation and r value are given.
Abbreviations: SNUH, Seoul National University Hospital; WBC, white blood cell; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RBC, red blood cell; RDW, RBC distribution width; PCT, plateletcrit; MPV, mean platelet volume; Hct, hematocrit.
Fig. 2
Scatter plots of coagulation test results showing age-dependent changes. Results obtained at SNUH using the ACL TOP analyzer (Instrumentation Laboratory, Bedford, MA, USA) after outlier exclusion are presented. (A–D) PT INR, PT percentage, PT, and fibrinogen. Blue and red dots represent male and female children enrolled in the present study. The gray line represents the trend line; its equation and r value are given.
Abbreviations: SNUH, Seoul National University Hospital; PT, prothrombin time; INR, international normalized ratio.
Fig. 3
Scatter plots of clinical chemistry results showing age-dependent changes. Reference intervals established in a previous study based mainly on a Caucasian population [8] are indicated as horizontal dashed lines. All test results that passed method comparison, considered mergeable, and subsequently used in multicenter analysis are plotted. (A–H) Calcium, phosphorus, BUN, uric acid, total protein, ALP, AST, and ALT. (I–L), creatinine, sodium, potassium, and TCO2. Blue and red dots represent male and female children enrolled in the present study. Blue, red, and black dashed lines represent male, female, and common reference limits established in a previous study, respectively. The gray line represents the trend line; its equation and r value are given.
Abbreviations: BUN, blood urea nitrogen; ALP alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
Table 1
Age- and sex-specific pediatric reference intervals for hematology testing using the Sysmex XE-2100 system
Analyte (unit) Total N Age Sex N Lower limit (90% CI) Upper limit (90% CI)
WBC (× 109/L) 385 0–3 mo M 17 6.48 (4.74–8.10) 16.30 (14.52–17.68)
F 17 5.78 (4.12–7.66) 15.80 (14.05–17.00)
4–11 mo Both 67 4.64 (3.78–5.42) 13.85 (12.98–14.77)
1–6 yr Both 138 4.85 (4,62–5,60) 11.50 (11.09–11.90)
7–18 yr Both 146 4,32 (2,72–4,62) 10.22 (9.57–10.20)
ANC (× 109/L) 383 0–11 mo Both 97 0.65* (N/A) 3.35* (N/A)
1–18 yr Both 286 1.40 (1.22–1.51) 5.76 (5.42–5.96)
Segmented neutrophils (%) 393 0–11 mo Both 101 3.3 (1.1–5.5) 33.1 (30.1–35.6)
1–6 yr Both 147 16.9 (12.8–19.0) 62.2 (56.3–65.6)
7–12 yr Both 46 28.4 (25.1–32.2) 64.5 (60.5–68.3)
13–18 yr Both 99 38.3 (36.4–40.3) 67.7 (65.6–69.8)
Lymphocytes (%) 391 0–11 mo Both 100 54.5 (52.0–57.6) 87.6 (85.2–89.8)
1–6 yr Both 147 26.9 (24.9–35.1) 73.8 (72.6–77.5)
7–12 yr Both 45 29.4 (26.2–32.8) 59.3 (56.3–62.0)
13–18 yr Both 99 21.5 (19.3–23.6) 51.5 (49.5–53.6)
Monocytes (%) 387 All Both 387 3.5 (3.0–3.7) 10.4 (10.0–10.7)
Eosinophils (%) 375 All M 181 0.3 (0.1–0.7) 6.9 (6.4–7.3)
F 194 0.4 (0.1–0.7) 5.7 (4.9–5.9)
Basophils (%) 380 All Both 380 0.1 (0.1–0.1) 0.8 (0.8–0.9)
RBC (× 106/µL) 390 0–3 mo Both 32 3.22 (3.07–3.41) 4.65 (4.44–4.82)
4 mo–18 yr M 174 4.16 (4.09–4.29) 5.49 (5.30–5.62)
F 184 4.03 (3.86–4.10) 5.16 (5.03–5.29)
MCV (fL) 395 0–3 mo Both 35 73.9 (71.2–76.6) 98.3 (95.2–100.9)
4–11 mo M 34 68.6 (66.9–70.6) 82.8 (81.0–84.5)
F 35 70.8 (69.1–72.5) 84.6 (82.8–86.2)
1–6 yr M 73 72.3 (71.5–73.2) 83.4 (82.5–84.3)
F 72 73.9 (72.8–75.0) 86.1 (85.2–87.0)
7–12 yr M 22 74.7 (73.1–76.6) 87.8 (85.7–89.8)
F 26 78.3 (77.0–79.9) 89.0 (87.6–90.3)
13–15 yr M 27 76.4 (74.3–78.7) 93.3 (91.1–95.3)
F 35 80.5 (79.0–82.1) 94.3 (92.6–96.0)
16–18 yr M 18 80.3 (78.3–82.6) 95.2 (92.4–97.8)
F 18 83.4 (81.6–85.6) 95.9 (93.9–97.5)
MCH (pg) 390 0–3 mo Both 35 25.3 (24.4–26.4) 33.7 (32.7–34.6)
4–11 mo M 32 23.5 (22.8–24.2) 28.6 (28.0–29.2)
F 31 24.9 (24.5–25.4) 28.2 (27.9–28.5)
1–6 yr Both 146 24.6 (24.3–25.2) 29.1 (28.8–29.3)
7–12 yr Both 48 26.4 (26.0–26.7) 30.4 (29.9–30.8)
13–15 yr Both 62 26.4 (25.8–26.9) 32.2 (31.7–32.7)
16–18 yr Both 36 28.0 (27.5–28.6) 32.3 (31.8–32.8)
MCHC (g/L) 386 0–12 yr Both 298 327 (325–329) 359 (357–364)
13–18 yr M 44 325 (322–328) 357 (354–360)
F 44 323 (321–326) 343 (341–345)
Hb (g/L) 393 0–3 mo Both 33 97 (92–101) 134 (128–140)
4 mo–6 yr Both 214 108 (107–111) 140 (138–143)
7–12 yr M 23 117† (112–123) 154† (148–159)
F 25 115 (110–120) 148 (143–152)
13–15 yr M 27 124 (119–129) 164 (158–169)
F 34 118 (114–122) 150 (146–152)
16–18 yr M 18 138† (132–143) 170† (164–176)
F 19 119† (114–123) 146† (141–151)
Hct (proportion of 1.0) 380 0–3 mo Both 27 0.31 (0.30–0.31) 0.36 (0.36–0.37)
4 mo–6 yr Both 211 0.33 (0.32–0.33) 0.40 (0.39–0.41)
7–12 yr Both 48 0.34 (0.34–0.35) 0.43 (0.42–0.44)
13–15 yr M 27 0.36 (0.34–0.37) 0.48 (0.46–0.50)
F 34 0.36 (0.35–0.37) 0.44 (0.43–0.45)
16–18 yr M 18 0.40 (0.39–0.42) 0.50 (0.49–0.52)
F 15 0.36† (0.35–0.37) 0.42† (0.41–0.43)
RDW (%) 390 0–3 mo Both 35 11.7 (11.2–12.2) 16.3 (15.7–16.8)
4 mo–6 yr M 105 12.0 (11.8–12.1) 14.4 (14.2–14.6)
F 106 11.7 (11.5–11.9) 14.1 (13.9–14.3)
7–18 yr Both 144 11.7 (11.3–11.9) 13.8 (13.6–13.8)
ESR (mm/hr) 225 All Both 225 2 (2–2) 9 (8–9)
Platelets (× 109/L) 390 0–3 mo Both 35 188 (143–243) 610 (558–663)
4–11 mo Both 65 199 (174–224) 495 (467–520)
1–12 yr Both 192 178 (171–192) 414 (389–434)
13–18 yr Both 98 165 (151–179) 365 (351–379)
PCT (%) 390 0–11 mo Both 102 0.17 (0.15–0.19) 0.52 (0.49–0.54)
1–18 yr Both 288 0.17 (0.15–0.18) 0.38 (0.36–0.39)
MPV (fL) 373 0–6 yr Both 236 7.6 (7.5–8.0) 10.9 (10.5–11.1)
7–18 yr Both 137 8.8 (8.6–9.1) 11.4 (11.1–11.8)
PDW (%) 358 All Both 358 8.4 (8.1–8.6) 13.3 (12.9–13.7)

*Although the sample size was <120, the values presented were established using a nonparametric method because the 90% CI of the reference lower limit calculated using the robust method contained a negative value and the data did not pass a normality test; The 90% CI was not determined using the robust method; however, the data passed a normality test and a parametric method based on the normal distribution was applied.

Abbreviations: CI, confidence interval; N/A, not applicable; yr, year; mo, month; M, male; F, female; ANC, absolute neutrophil count; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW, red cell distribution width; PCT, plateletcrit; MPV, mean platelet volume; PDW, platelet distribution width; WBC, white blood cells; RBC, red blood cells; MCV, mean corpuscular volume; ESR, erythrocyte sedimentation rate; Hct, hematocrit.

Table 2
Age-specific pediatric reference intervals for coagulation testing using the ACL TOP system
Analyte (unit) Total N Age Sex N Lower limit (90% CI) Upper limit (90% CI)
PT INR 389 0–11 mo Both 102 0.87 (0.85–0.89) 1.14 (1.12–1.16)
1–18 yr Both 287 0.93 (0.91–0.94) 1.17 (1.15–1.19)
PT (%) 392 0–11 mo Both 100 82 (79–84) 117 (114–120)
1–18 yr Both 292 78 (73–81) 111 (109–114)
PT (s) 387 0–11 mo Both 100 9.6 (9.4–9.8) 12.3 (12.1–12.5)
1–18 yr Both 287 10.1 (10.0–10.3) 12.8 (12.6–13.1)
aPTT (s) 383 All Both 383 28.3 (27.5–29.0) 41.3 (40.8–41.7)
Fibrinogen (g/dL) 67 0–12 yr Both 56 1.46 (1.31–1.63) 3.21 (3.04–3.35)
13–18 yr Both 11 1.96* (1.54–2.37) 3.79* (3.38–4.21)

*The 90% CI was not determined using a non-parametric method or robust method; however, the data passed a normality test and a parametric method based on the normal distribution was applied.

Abbreviations: PT, prothrombin time; INR, international normalized ratio; aPTT, activated partial thromboplastin time; yr, year; mo, month.

Table 3
Age- and sex-specific pediatric reference intervals for chemistry testing using the TBA-c16000 system and multiple platforms, including Cobas 800, Hitachi 7600, and AU 5800, in the present study, and comparison with reference intervals from another single-center study in a Korean population and CALIPER study that were converted from conventional units to SI units
Analyte (unit) Total N Age Sex This study Severance Hospital [15] CALIPER [8]

N Lower limit (90% CI) Upper limit (90% CI) Age Lower limit Upper limit Age Lower limit Upper limit
Calcium (mmol/L) 387 0–11 mo Both 101 2.44 (2.41–2.47) 2.85 (2.82–2.87) 0–1 yr 2.13 2.75
1–6 yr Both 143 2.28 (2.23–2.33) 2.61 (2.60–2.70) 1–19 yr 2.30 2.63
7–18 yr Both 143 2.23 (2.20–2.25) 2.53 (2.48–2.53)
Multicenter combined (T+C+H) 780 0–11 mo Both 270 2.43 (2.40–2.48) 2.81 (2.80–2.85)
1–6 yr Both 280 2.28 (2.25–2.30) 2.67 (2.63–2.70)
7–18 yr Both 230 2.20 (2.15–2.23) 2.58 (2.55–2.63)
Phosphorus (mmol/L) 390 0–3 mo Both 32 1.74 (1.63–1.85) 2.54 (2.45–2.61) M: 2–16 yr 1.23 1.91
4–11 mo Both 68 1.57 (1.51–1.63) 2.29 (2.23–2.35) F: 2–14 yr 1.26 1.87
1–6 yr Both 147 1.42 (1.26–1.45) 2.07 (2.00–2.16)
7–12 yr M 23 1.26 (1.16–1.41) 2.02 (1.92–2.15)
F 23 1.15*(1.05–1.25) 1.80* (1.70–1.91)
13–18 yr Both 97 1.01 (0.96–1.06) 1.73 (1.67–1.78)
Glucose (mmol/L) 377 All Both 377 4.38 (4.11–4.44) 6.44 (6.33–6.49) M: 2–16 yr 4.16 6.49
Multicenter combined (T+C) 655 All Both 655 4.38 (4.16–4.50) 6.42 (6.33–6.49) F: 2–14 yr 4.11 6.72
BUN (mg/dL) 396 0–11 mo Both 101 0.40 (0.11–0.70) 5.17 (4.85–5.61) 0–14 d 1.00 8.21
1–18 yr Both 295 2.28 (2.14–2.50) 6.07 (6.07–6.43) 15 d–1 yr 1.21 6.00
1–10 yr 3.21 7.89
10–19 yr M: 2.61, F: 2.61 M: 7.50, F: 6.78
Uric acid (mmol/L) 357 0–3 mo Both 33 0.08 (0.06–0.10) 0.25 (0.23–0.27) M: 2–10 yr 0.15 0.35
4 mo–6 yr Both 204 0.12 (0.11–0.14) 0.30 (0.29–0.34) M: 11–16 yr 0.18 0.45
7–12 yr M 21 0.16 (0.14–0.19) 0.37 (0.33–0.40) F: 2–14 yr 0.15 0.35
F 25 0.12 (0.09–0.15) 0.37 (0.33–0.40)
13–18 yr M 34 0.23 (0.21–0.27) 0.46 (0.43–0.49)
F 40 0.16 (0.14–0.18) 0.36 (0.34–0.39)
Cholesterol (mmol/L) 388 All Both 388 2.95 (2.82–3.06) 5.64 (5.46–5.83) M: 2–16 yr 3.16 5.41 0–14 d M: 1.09, F: 1.19 M: 2.82, F: 3.24
Multicenter combined (T+H) 489 All Both 489 2.90 (2.82–3.03) 5.72 (5.52–5.85) F: 2–14 yr 3.32 5.46 15 d–1 yr 1.66 6.14
1–19 yr 2.90 5.39
Total Protein (g/L) 389 0–3 mo Both 32 53.6 (51.1–56.4) 75.0 (72.4–77.2) M: 2–5 yr 61 74 0–14 d 53 83
4–11 mo Both 70 58.5 (57.0–59.7) 74.7 (73.0–76.2) M: 6–16 yr 63 77 15 d–1 yr 44 71
1–6 yr Both 147 64.0 (61.0–64.0) 78.0 (76.0–79.0) F: 2–14 yr 63 77 1–6 yr 61 75
7–12 yr M 20 68.5* (67.2–69.8) 76.2* (74.9–77.5) 6–9 yr 64 77
F 25 65.0* (63.0–67.0) 78.8* (76.7–80.8) 9–19 yr 65 81
13–18 yr Both 95 68.7 (67.8–69.6) 80.9 (80.1–81.8)
Albumin§ (g/L) 394 All Both 394 40 (39–41) 50 (50–51) M: 2–16 yr 40 49 0–14 d 33 45
F: 2–14 yr 40 49 15 d–1 yr 28 47
1–8 yr 38 47
8–15 yr 41 48
15–19 yr M: 41, F: 40 M: 51, F: 49
Total bilirubin (µmol/L) 367 All Both 367 3.4 (3.4–3.4) 13.7 (13.7–13.7) M: 2–8 yr 3.4 13.7 0–14 d 3.2 283.9
M: 9–16 yr 3.4 17.1 15 d –1 yr 0.9 11.6
F: 2– 9 yr 3.4 13.7 1–9 yr 0.9 6.8
F: 10–14 yr 3.4 17.1 9–12 yr 0.9 9.4
12–15 yr 1.7 12.0
15–19 yr 1.7 14.4
ALP (µkat/L) 268 0–12 yr Both 212 2.01 (1.64–2.47) 5.75 (5.46–6.20) M: 2–5 yr 1.77 4.35 0–14 d 1.50 4.55
13–15 yr M 13 1.04* (0.08–2.00) 5.66* (4.71–6.62) M: 6–14 yr 1.97 5.68 15 d–1 yr 2.23 8.63
F 17 0.92 (N/A) 2.76 (N/A) M: 15–16 yr 1.03 4.17 1–10 yr 2.60 6.15
16–18 yr M 13 0.96* (0.76–1.15) 1.89* (1.69–2.08) F: 2–5 yr 1.95 4.35 10–13 yr 2.35 7.67
F 13 0.57* (0.35–0.78) 1.61* (1.39–1.82) F: 6–12 yr 2.05 5.50 13–15 yr M: 2.12, F: 1.03 M: 8.62, F: 4.67
F: 13–14 yr 1.02 6.65 15–17 yr M: 1.48, F: 0.90 M: 6.08, F: 2.13
17–19 yr M: 0.98, F: 0.80 M: 2.73, F: 1.58
AST (GOT) (µkat/L) 376 0–11 mo Both 97 0.25 (0.19–0.33) 1.15 (1.07–1.24) M: 2–16 yr 0.25 0.65 0–14 d 0.53 2.70
1–6 yr Both 144 0.38 (0.35–0.40) 0.80 (0.75–0.85) F: 2–7 yr 0.33 0.68 15 d–1 yr 0.30 1.12
7–12 yr M 19 0.27* (0.21–0.33) 0.63* (0.57–0.69) F: 8–14 yr 0.23 0.57 1–7 yr 0.35 0.73
F 25 0.22* (0.17–0.26) 0.51* (0.47–0.56) 7–12 yr 0.30 0.60
13–18 yr Both 91 0.17 (0.16–0.19) 0.42 (0.39–0.43) 12–19 yr M: 0.23, F: 0.22 M: 0.58, F: 0.43
ALT (GPT) (µkat/L) 380 0–11 mo Both 98 0.23 (N/A) 1.01 (N/A) M: 2–16 yr 0.13 0.65 0–1 yr 0.08 0.55
1–18 yr Both 282 0.12 (0.12–0.13) 0.45 (0.43–0.52) F: 2–14 yr 0.12 0.52 1–13 yr 0.15 0.42
13–19 yr M: 0.15, F: 0.13 M: 0.40, F: 0.37
Creatinine| (µmol/L) 391 0–3 mo Both 33 13.4 (11.3–15.8) 31.7 (29.7–34.2) M: 2–5 yr 19.4 49.5 0–14 d 37.1 92.8
4–11 mo Both 69 18.5 (17.1–20.0) 33.4 (32.3–34.8) M: 6–9 yr 28.3 61.9 15 d–1 yr 28.3 46.9
1–6 yr Both 147 23.0 (18.6–23.9) 46.5 (43.3–47.1) M: 10–12 yr 34.5 70.7 1–4 yr 33.6 47.7
7–12 yr Both 48 30.2 (27.4–33.5) 66.2 (62.0–70.0) M: 13–16 yr 39.8 86.6 4–7 yr 38.9 56.6
13–15 yr M 27 38.7 (31.8–47.4) 97.1 (89.4–104.3) F: 2–5 yr 18.6 46.9 7–12 yr 46.0 61.0
F 30 44.4 (41.2–48.3) 71.7 (68.1–75.7) F: 6–8 yr 28.3 56.6 12–15 yr 50.4 70.7
16–18 yr M 18 61.7* (54.5–68.9) 102.8* (95.6–110.0) F: 9–14 yr 32.7 63.6 15–17 yr M: 58.3, F: 52.2 M: 91.9, F: 76.0
F 19 48.9* (44.0–53.8) 77.8* (72.9–82.7) 17–19 yr M: 61.0, F: 53.0 M: 97.2, F: 77.8
Na (mmol/L) 392 0–6 yr Both 248 134 (133–134) 141 (140–141)
7–18 yr Both 144 136 (135–136) 142 (142–143)
Multicenter combined (T+C+A) 909 0–3 mo Both 42 132 (131–133) 142 (141–143)
4 mo–6 yr Both 603 135 (135–136) 143 (142–143)
7–18 yr Both 264 136 (135–136) 144 (143–144)
K (mmol/L) 389 0–3 mo Both 33 4.5 (4.2–4.7) 6.3 (6.1–6.5)
4–11 mo Both 67 4.1 (4.0–4.2) 5.3 (5.2–5.4)
1–18 yr Both 289 3.7 (3.6–3.7) 4.8 (4.7–4.9)
Multicenter combined (T+C+A) 911 0–3 mo M 20 4.7* (4.4–4.9) 6.2* (5.9–6.4)
F 21 4.3* (4.0–4.6) 6.2* (5.9–6.5)
4–11 mo Both 248 4.2 (4.0–4.3) 5.4 (5.3–5.5)
1–18 yr Both 622 3.7 (3.7–3.8) 5.0 (4.9–5.1)
Cl (mmol/L) 398 All Both 398 100 (99–100) 108 (108–109)
Multicenter combined (T+C+A) 890 All Both 890 101 (100–101) 107 (107–108)
TCO2 (mmol/L) 393 0–6 yr Both 248 17 (17–18) 26 (26–28) 0–14 d 5 20
7–12 yr Both 47 21 (N/A) 29 (N/A) 15 d–1 yr 10 24
13–18 yr Both 98 21 (20–22) 31 (30–32) 1–5 yr 14 24
5–15 yr 17 26
15–19 yr M: 18, F: 17 M: 28, F: 26
CRP (mg/L) 241 All Both 241 0.10 (0.10–0.10) 1.80 (1.70–2.30) 0–14 d 0.3 6.1
15 d–15 yr 0.1 1.0
15–19 yr 0.1 1.7

*The 90% CI was not determined using the robust method; however, the data passed a normality test and a parametric method based on the normal distribution was applied; Although the sample size was <120, the values presented were established using a nonparametric method because the 90% CI calculated using the robust method contained a negative value; Age-specific group for the CALIPER study described as “A-B” means equal to or older than A, and younger than B; §Albumin concentration was measured using a bromocresol green dye-binding assay (AlbBCG). |Creatinine was measured using the Jaffe reaction.

Abbreviations: CALIPER, Canadian laboratory initiative on pediatric reference interval database; T, TBA-c16000; C, Cobas 800; H, Hitachi 7600; d, day; mo, month; yr, year; A, AU 5800; BUN, blood urea nitrogen; ALP, alkaline phosphatase; AST, aspartate aminotransferase; GOT, glutamate oxaloacetate transaminase; ALT, alanine aminotransferase; GPT, glutamate pyruvate transaminase; TCO2, total CO2; CRP, C-reactive protein.

Similar articles